Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

    From Pfizer, Inc.

    The funder's mission is to improve outcomes for patients with advanced prostate cancer and to advance research, innovation, clinical expertise, and education for healthcare professionals in Latin America.

    Type of Support

    Overview

    This competitive grant program aims to support local-level educational activities for healthcare professionals involved in treating heart failure patients at risk for TTR Amyloidosis. It encourages organizations to identify and address the educational needs of these professionals to enhance awareness and facilitate early and appropriate patient identification through an evidence-based approach. Applications are accepted on a rolling basis until funds are depleted.

    Eligibility

    Organization's Location
    proident Lorem
    Program Location
    elit
    Organization Type
    10K – 20K

    Submission

    Visit Apply for more information.

    Similar grants